You are here: Fairness.com > Resources > Institute of Medicine (IOM)

Institute of Medicine (IOM)


Self Description

December 2002:"The Institute provides objective, timely, authoritative information and advice concerning health and science policy to government, the corporate sector, the professions and the public."
http://www.iom.edu/iom/iomhome.nsf/Pages/About+the+IOM

"The IOM is governed by a Council consisting of the president and 20 members elected by the membership to 3-year terms."
http://www.iom.edu/iom/iomhome.nsf/pages/IOM+Council
"The National Academy of Sciences...and its associated organizations (e.g., the Institute of Medicine) are private, non-governmental, organizations and do not receive direct federal appropriations for their work. the IOM process establishes it as an independent body, with its use of unpaid volunteer experts who author most reports."
http://www.iom.edu/iom/iomhome.nsf/Pages/IOM+FAQs

Third-Party Descriptions

December 2011: "The report that prompted Dr. Collins’s announcement came from the Institute of Medicine, one of the National Academies. It was commissioned by the N.I.H. to assess the necessity of using chimpanzees in research. It is well written as reports go, and its intentions are as clear as Dr. Collins’s acceptance of it. But it also suggests the weight and intricacy of words and how they affect whether a chimpanzee will be injected."

http://www.nytimes.com/2011/12/20/science/recognition-of-chimps-as-relatives-may-reshape-research.html

July 2011: "Instead, as patients and their doctors try to make critical decisions about serious illnesses, they may be getting worthless information that is based on bad science. The scientific world is concerned enough that two prominent groups, the National Cancer Institute and the Institute of Medicine, have begun examining the Duke case; they hope to find new ways to evaluate claims based on emerging and complex analyses of patterns of genes and other molecules."

http://www.nytimes.com/2011/07/08/health/research/08genes.html

December 2008: '“We haven’t been forthright about the dirty little secret, the huge variation of quality and safety in the system,” said Arthur Aaron Levin, director of the Center for Medical Consumers, a nonprofit patient advocacy group. Nearly a decade after the Institute of Medicine report, preventable errors remain shockingly common, said Mr. Levin, who was a member of the commission that wrote the report.'

http://www.nytimes.com/2008/12/08/business/08hospital.html

May 2008: "The Sentinel Initiative has been in the works for years. In 2005, Mr. Leavitt asked the F.D.A. to explore the creation of such a system. In 2006, the Institute of Medicine recommended one, and last fall Congress voted to require the agency to create such a system."

http://www.nytimes.com/2008/05/23/washington/23fda.html

January 2007: Officials outlined plans to better monitor safety problems after drugs are approved and to make internal changes to increase the profile of agency scientists who raise red flags about drugs. The steps were announced in response to a report last year by the congressionally chartered Institute of Medicine (IOM) that called for an overhaul of the FDA's culture and structure following safety controversies over drugs such as the painkiller Vioxx.

http://www.washingtonpost.com/wp-dyn/content/article/2007/01/30/AR2007013001496.html

August 2006: Under current regulations, passed in 1978, prisoners can participate in federally financed biomedical research if the experiment poses no more than “minimal” risks to the subjects. But a report formally presented to federal officials on Aug. 1 by the Institute of Medicine of the National Academy of Sciences advised that experiments with greater risks be permitted if they had the potential to benefit prisoners. As an added precaution, the report suggested that all studies be subject to an independent review.

http://www.nytimes.com/2006/08/13/us/13inmates.html

Relationships

RoleNameTypeLast Updated
Owned by (partial or full, past or present) National Academies Organization Mar 23, 2004
Member (past or present) Dr. David Blumenthal M.D., MPP Person Jan 25, 2006
Member (past or present) Prof. Arthur Kleinman M.D. Person Apr 27, 2010
Cooperation (past or present) Arthur A. Levin M.P.H. Person Nov 16, 2008
Member (past or present) Prof. Alicia H. Munnell Ph.D. Person Aug 17, 2006
Organization Head/Leader (past or present) Prof. David J. Rothman Person Jan 25, 2006
Member (past or present) Prof. Jeffrey D. Sachs Person Dec 18, 2005
Director/Trustee/Overseer (past or present) Andrew L. Stern Person Aug 15, 2006

Articles and Resources

36 Articles and Resources. Go to:  [Next 16]

Date Fairness.com Resource Read it at:
Dec 11, 2012 Scientists Propose Central Database for Disclosing Conflicts of Interest

QUOTE: a lack of standardization in COI disclosures increases the administrative burden on physicians and increases the chances of being accused of incomplete and misleading statements. As a solution, their committee — facilitated by the Institute of Medicine — recommends the creation of a centralize database for the disclosure and reporting of interests.

 Scholarly Kitchen
Dec 19, 2011 Elevation of the Chimp May Reshape Research

QUOTE: When Dr. Francis S. Collins, the head of the National Institutes of Health, announced Thursday that the government would halt all new grants for research on chimpanzees....N.I.H. is the source of a river of money that flows into labs around the country where animals in the millions are, to misuse the words of an old Arlo Guthrie song, “injected, inspected, detected, infected” and a few other things, all in the cause of increasing knowledge and alleviating human suffering, of course.

 New York Times
Jul 07, 2011 How Bright Promise in Cancer Testing Fell Apart

QUOTE: as patients and their doctors try to make critical decisions about serious illnesses, they may be getting worthless information that is based on bad science. The scientific world is concerned enough that two prominent groups, the National Cancer Institute and the Institute of Medicine, have begun examining the Duke case; they hope to find new ways to evaluate claims based on emerging and complex analyses of patterns of genes and other molecules.

 New York Times
Oct 10, 2009 The Gift of Life, and Its Price (21st Century Babies)

QUOTE: While IVF creates thousands of new families a year, an increasing number of the newborns are twins, and they carry special risks often overlooked in the desire to produce babies.

 New York Times
Sep 24, 2009 F.D.A. Reveals It Fell to a Push by Lawmakers

QUOTE: The Food and Drug Administration said Thursday that four New Jersey congressmen and its own former commissioner unduly influenced the process that led to its decision last year to approve a patch for injured knees, an approval it is now revisiting.

 New York Times
Aug 24, 2009 Dialysis treatment in USA: High costs, high death rates

QUOTE: Although the USA spends more per dialysis patient than other countries, that does not result in higher survival rates or even, many argue, a better quality of life.

 USA TODAY
Jun 15, 2009 Tobacco Regulation Is Expected to Face a Free-Speech Challenge

QUOTE: The marketing and advertising restrictions in the tobacco law that Congress passed last week are likely to be challenged in court on free-speech grounds. The controversy... involves tension between the right of tobacco companies to communicate with adult smokers and the public interest in preventing young people from smoking.

 New York Times
Apr 21, 2009 Rare F.D.A. Meeting to Discuss Complaints on Device Approval

QUOTE: Nine dissident scientists signed letters to President Obama and others in the administration charging that agency officials had acted illegally and that patients were routinely put at risk by medical devices approved for sale despite significant and often unanimous objections from scientific reviewers.

 New York Times
Dec 08, 2008 The Evidence Gap: Weak Patchwork of Oversight Lets Bad Hospitals Stay Open

QUOTE: in late 2006 a state commission recommended that it be scaled back and merged with another hospital. The state’s inability to follow through on that plan for University provides a stark example of how hard it can be — not just in New York, but around the nation — to close or shrink hospitals, even when there is evidence they are providing costly and below-average care.

 New York Times
May 23, 2008 F.D.A. to Expand Scrutiny of Risks From Drugs After They’re Approved for Sale

QUOTE: The agency now relies on an unsystematic system in which doctors, patients and manufacturers report problems with drugs and medical devices when they deem them important. One doctor might see an infection following the use of a drug as important to report while another might not. The agency estimates that it receives reports for only a fraction of actual drug effects.

 New York Times
May 19, 2008 Inertia at the Top: Belated, Patchy Response Further Hamstrung By Inadequate Federal Attention, Experts Say ("Young Lives at Risk: Our Overweight Children" part 2 of 5)

QUOTE: "The sense of this as a national health priority just doesn't come through," said Jeffrey P. Koplan...The top recommendation of that seminal report was for the government to convene a high-level, interdepartmental task force to guide a coordinated response. No such body has been assembled.

 Washington Post
Jun 10, 2007 Fight Over Vaccine-Autism Link Hits Court: Families, After Having Claims Rejected by Experts, Face Lower Burden of Proof

QUOTE: For more than a decade, families across the country have been warring with the medical establishment over their claims that routine childhood vaccines are responsible for the nation's apparent epidemic of autism. In an extraordinary proceeding that begins tomorrow, the battle will move from the ivory tower to the courts.

 Washington Post
Jan 31, 2007 FDA Revamps Process for Safety of Drugs After Approval

QUOTE: [The Food and Drug Administration--Ed.]outlined plans to better monitor safety problems after drugs are approved and to make internal changes to increase the profile of agency scientists who raise red flags about drugs.

 Washington Post
Jan 22, 2007 Showdown Looms in Congress Over Drug Advertising on TV

QUOTE: "Criticism of direct-to-consumer advertising has intensified since 2004, after Merck withdrew Vioxx, a heavily advertised painkiller, after a clinical trial showed that it sharply increased the risk of heart attacks and strokes."

 New York Times
Nov 21, 2006 Studies: Hospitals Could Do More to Avoid Infections: Poor Hygiene, Operating Room Traffic, Antibiotic Use Are Cited

QUOTE: "Infections acquired in hospitals, which take a heavy toll on patients, arise mainly from poor hygiene in hospital procedures, not from how sick patients were when they were admitted, according to three new studies."

 Washington Post
Nov 18, 2006 FDA Ends Ban on Silicone Implants: Safety Concerns Led to '92 Moratorium

QUOTE: "The Food and Drug Administration ended its 14-year ban on the cosmetic use of silicone breast implants yesterday, despite lingering safety concerns from some health advocates."

 Washington Post
Oct 10, 2006 Report Faults FDA on Drug Safety

QUOTE: Five experts...said FDA-mandated safety studies can miss serious problems with a drug both before and after its approval.

 Washington Post
Sep 12, 2006 10 Things Your Hospital Won't Tell You

QUOTE: in recent years errors in treatment have become a serious problem for hospitals, ranging from operating on the wrong body part to medication mix-ups.

 Smart Money
Aug 23, 2006 Safe Drug Testing in Prisons

QUOTE: The savage and dishonorable legacy of drug testing in prison makes it imperative that any change be carried out carefully, with maximum transparency and concern for inmate safety. That will require far more federal oversight than current law provides.

 New York Times
Aug 18, 2006 Fewer Vietnam Vets Are Found to Have Stress Disorder: New Study Is Criticized for Using Narrow Criteria for Condition

QUOTE: The report's suggestion that one in five Vietnam veterans had the syndrome at some point in the first dozen years after the war...But other experts and some veterans groups criticized the study, saying it used criteria so narrow that it excluded many vets who should have been included.

 Washington Post

36 Articles and Resources. Go to:  [Next 16]